Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

US Patent 10385024 · Granted Aug 20, 2019

Estimated economic value: $3,346,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody and use there2025
Anti-human interleukin-33 monoclonal antibody and use thereof2025
Methods and compounds useful in the synthesis of an AAK1 inhibitor2025
Compounds useful for treating gastrointestinal tract disorders2025
ASGPR cell surface receptor binding compounds and conjugates2025
Hormone receptor modulators for treating metabolic conditions and disorders2025
Allosteric enhancing compound of GABAA receptor and preparation and use thereof2024
Anti-human interleukin 17A monoclonal antibody and application thereof2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024